Working… Menu

Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT00921986
Recruitment Status : Recruiting
First Posted : June 17, 2009
Last Update Posted : May 15, 2019
Information provided by (Responsible Party):
Mina Chung, MD, The Cleveland Clinic

Brief Summary:
Biorepository of blood and or tissue samples from patients presenting with cardiac arrhythmia syndromes.

Condition or disease
Arrhythmias, Cardiac

Detailed Description:
The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and control subjects without arrhythmias. This biorepository will be composed of two parts: 1) An Arrhythmia Biorepository of blood and tissue from patients undergoing arrhythmia procedures, cardiac surgery, or inpatient or outpatient evaluations for arrhythmias, and 2) A Collaborative Sample Biorepository for de-identified samples and data from outside institutions and clinical trials.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Cleveland Clinic Arrhythmia Biospecimen Repository (Cleveland Clinic Arrhythmia BioBank)
Actual Study Start Date : March 2009
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : April 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Arrhythmia

Patients with arrhythmias
Control Subjects
Subjects that do not have a history of cardiac arrhythmias.

Primary Outcome Measures :
  1. Genetic variants associated with arrhythmias [ Time Frame: Baseline ]
    Genome-wide association study of arrhythmias

Biospecimen Retention:   Samples With DNA
Biospecimens to be collected: DNA, RNA, plasma, & serum. Also tissue may be collected.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing arrhythmia procedures, cardiac surgery or inpatient or outpatient evaluations for arrhythmias at the Cleveland Clinic or from outside collaborative institutions or from other clinical trials.

Inclusion Criteria:

  • Male or female at least 18 years old
  • Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject.

Exclusion Criteria:

  • Subjects previously enrolled in the Arrhythmia BioBank

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00921986

Layout table for location contacts
Contact: Mina K. Chung, MD 216.444.2290

Layout table for location information
United States, Ohio
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Principal Investigator: Mina K. Chung, MD         
Sub-Investigator: David R. Van Wagoner, Ph.D.         
Sub-Investigator: Jonathan D. Smith, Ph.D.         
Sub-Investigator: John Barnard, Ph.D.         
Sponsors and Collaborators
The Cleveland Clinic
Layout table for investigator information
Principal Investigator: Mina K. Chung, MD The Cleveland Clinic

Layout table for additonal information
Responsible Party: Mina Chung, MD, Principal Investigator, The Cleveland Clinic Identifier: NCT00921986     History of Changes
Other Study ID Numbers: 09-176
First Posted: June 17, 2009    Key Record Dates
Last Update Posted: May 15, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mina Chung, MD, The Cleveland Clinic:
sinus node dysfunction
cardiac death
atrial fibrillation
ventricular fibrillation
ventricular tachycardia
supraventricular tachycardias
premature ventricular complexes
premature atrial complexes
atrioventricular and intraventricular blocks
vasovagal reactivity
postural orthostatic tachycardia syndrome
Additional relevant MeSH terms:
Layout table for MeSH terms
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes